Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.

Journal of Clinical Microbiology
Franz-Josef SchmitzAd C Fluit

Abstract

Of the 419 Moraxella catarrhalis isolates collected during the 1997-1999 European SENTRY surveillance study, 385 (92%) were beta-lactamase positive. Twenty-two (5.7%) produced BRO-2 beta-lactamase. Twenty-one new mutations were found in the putative promoter region of the bro genes. Nineteen percent of all isolates tested were complement sensitive. Resistance to beta-lactams is not linked to the phylogenetic lineages associated with susceptibility to complement.

References

Jun 1, 1995·FEMS Immunology and Medical Microbiology·C HolH van Dijk
May 1, 1995·Clinical and Diagnostic Laboratory Immunology·C M VerduinH Van Dijk
Dec 1, 1994·The Journal of Infectious Diseases·C HolH van Dijk
Feb 1, 1994·The Journal of Antimicrobial Chemotherapy·C P FungD M Livermore
Sep 1, 1996·The Journal of Infectious Diseases·C HolH Van Dijk
Apr 1, 1996·Antimicrobial Agents and Chemotherapy·H J BootsmaF R Mooi
Jul 1, 1996·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·T Ejlertsen, R Skov
Oct 1, 1996·The Journal of Antimicrobial Chemotherapy·D FelminghamR N Grüneberg
May 1, 1997·Journal of Medical Microbiology·M C Enright, H McKenzie
Aug 26, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K McGregorT V Riley
Dec 16, 2000·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B WolfA van Belkum

❮ Previous
Next ❯

Citations

Aug 12, 2009·Infection and Immunity·Rachel BalderEric R Lafontaine
Nov 8, 2003·Journal of Clinical Microbiology·Noriyuki NaganoMatsuhisa Inoue
Apr 2, 2008·Expert Review of Vaccines·Thuan Tong Tan, Kristian Riesbeck
Aug 17, 2004·Scandinavian Journal of Infectious Diseases·Ozgen KöseogluGülsen Hascelik
May 18, 2017·Vestnik otorinolaringologii·I N ProtasovaT S Podgrushnaya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.